ArticleJournal of experimental & clinical cancer research : CR2022

Brucein D augments the chemosensitivity of gemcitabine in pancreatic cancer via inhibiting the Nrf2 pathway.

Juan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.